Hologic is the global leader in women's health imaging and one of the world's leading diagnostic imaging companies.
Hologic is the world's leading company in women's health, with a diagnostic imaging portfolio concentrated in mammography, breast biopsy, and bone densitometry. The company's Genius 3D Mammography system — combining digital breast tomosynthesis with AI-powered reading assistance — is the market-leading mammography platform globally, with an installed base of thousands of systems across the United States, Europe, and international markets. Hologic's imaging revenue of approximately $1 billion represents the majority of its breast health segment. The company's focused specialization in women's health creates a highly defensible competitive position in mammography against larger multi-modality OEMs.
This report provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs.
Topics Covered
• Financial performance 2023-2025
• SWOT analysis
• Technological know-how and key platforms
• Latest products, programs, and AI portfolio
• M&A and partnership activity 2023-2025
• Marketing tactics and commercial strategy
• Organization and management
Table of Contents
1. Executive Summary
2. Company Overview
3. Strategic Directions
4. Financial Performance
5. SWOT Analysis
6. Technological Know-How and Key Products
7. M&A and Partnerships
8. Marketing Tactics
9. Organization and Management
10. Appendix
List of Tables
Table 1. Hologic — Key Financial Metrics 2023-2025
Table 2. Hologic — Revenue by Modality 2023-2025
Table 3. Hologic — Revenue by Geography 2023-2025
Table 4. Hologic — R&D Investment 2023-2025
Table 5. Hologic — SWOT Analysis
Table 6. Hologic — Key Products and Platforms 2025
Table 7. Hologic — M&A Activity 2020-2025
Table 8. Hologic — Key Management 2025
Table 9. Hologic — Strategic Priorities 2025-2030
